LFE life therapeutics limited

life therapeutics to supply anti anthrax plasma

  1. fluffynymph
    56,898 Posts.
    lightbulb Created with Sketch. 288
    clock Created with Sketch.
    06/09/06
    12:11
    Post #: 1778100
    Sydney - Wednesday - September 6: (RWE Aust Business News) - Life
    Therapeutics (ASX:LFE) will supply Cangene Corp with anti-anthrax plasma
    to produce a hyperimmune product for the US Department of Health and
    Human Services.
    This is a $US143m project for Cangene under Project BioShield to
    produce 10,000 doses of anthrax immune globulin for treating inhalational
    anthrax.
    LFE Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.